Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders

 
 

ALPINE IMMUNE SCIENCES, INC. (NVLS) Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15
Revenues30.123.49.31.70.71.73.00.5
            Revenue growth28.2%151.1%436.5%146.8%-59.3%-41.3%499.6% 
Cost of goods sold0.00.00.00.00.00.00.00.0
Gross profit30.123.49.31.70.71.73.00.5
            Gross margin100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%
Research and development70.258.727.235.829.010.63.00.4
General and administrative18.014.610.99.58.46.11.10.4
EBIT-58.1-49.9-28.7-43.6-36.6-15.0-1.2-0.4
            EBIT margin-193.4%-212.7%-308.0%-2504.3%-5195.3%-865.0%-40.3%-75.4%
Pre-tax income-55.4-50.4-27.9-41.9-36.9-8.0-1.2-0.4
Income taxes2.3-0.10.00.0-0.4-0.20.10.0
            Tax rate 0.2%0.0%0.0%1.0%2.5% 0.0%
Net income-57.8-50.3-27.9-41.9-36.5-7.8-1.2-0.4
            Net margin-192.1%-214.7%-299.3%-2405.3%-5175.5%-449.6%-41.8%-75.0%
 
Diluted EPS($1.73)($1.98)($1.34)($2.28)($2.63)($1.20)($2.18)($0.74)
Shares outstanding (diluted)33.425.520.818.413.86.50.60.5
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy